Balyasny Asset Management
EXAS

Balyasny Asset Management’s Exact Sciences EXAS Stock Holding History

Balyasny Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,900
Closed -$2.53M – 3070
2025
Q4 		$2.53M Buy
24,900
+17,100
+219% +$1.37M ﹤0.01% 1749
2025
Q3 		$427K Sell
7,800
-40,600
-84% -$2.03M ﹤0.01% 2454
2025
Q2 		$2.57M Buy
+48,400
New +$2.46M ﹤0.01% 1602
2025
Q1 		– Sell
-14,500
Closed -$815K – 2926
2024
Q4 		$815K Buy
14,500
+2,200
+18% +$137K ﹤0.01% 2018
2024
Q3 		$838K Buy
+12,300
New +$694K ﹤0.01% 2039
2024
Q2 		– Sell
-5,900
Closed -$407K – 2720
2024
Q1 		$407K Buy
+5,900
New +$373K ﹤0.01% 2133
2023
Q1 		– Sell
-76,300
Closed -$3.78M – 2806
2022
Q4 		$3.78M Sell
76,300
-62,300
-45% -$2.55M 0.01% 1145
2022
Q3 		$4.5M Buy
138,600
+33,100
+31% +$1.36M 0.01% 1057
2022
Q2 		$4.16M Buy
+105,500
New +$5.64M 0.01% 1017

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Balyasny Asset Management's EXAS Position: Q1 2026 in Review

Balyasny Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 4,089,977 shares — an estimated $415M sold.

Balyasny Asset Management first reported a position in EXAS in Q4 2015 and held it in 23 quarters. The position peaked at $415M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Balyasny Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 4,089,977 Exact Sciences shares in Q1 2026, an estimated $415M.
  • Balyasny Asset Management first reported a position in Exact Sciences in Q4 2015 and held it in 23 quarters.
  • Balyasny Asset Management's Exact Sciences position peaked at $415M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.